PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of atmHomeCurrent issueInstructionsSubmit article
 
Ann Thorac Med. 2012 Apr-Jun; 7(2): 57–60.
PMCID: PMC3339204

Surgical management of retrosternal goiter: Local experience at a university hospital

Abstract

BACKGROUND AND OBJECTIVE:

Retrosternal goiter (RSG) is a term that has been used to describe a goiter that extends beyond the thoracic inlet. Surgery plays an important role in the treatment of these patients, but whether all or selected patients with RSG should undergo this operation remains controversial. Our aim is to look into the demographics, presentation, and treatment of patients with RSG and essentially to determine the role of surgery in its treatment.

SETTING AND DESIGN:

Retrospective study, teaching hospital-based.

METHODS:

Retrospective analysis of 537 thyroidectomies performed at King Khalid University Hospital between 2003 and 2010. The twenty-six patients with RSG were analyzed further, with regard to demographics, presentation, indications, and outcome of surgical treatment. Statistical analysis was performed, where age was expressed as mean and range, and other variables were presented as numbers and percentage.

RESULTS:

There were 26 patients (4.8%) with RSG out of 537 thyroidectomies, who underwent an operation for removal of RSGs, in a seven-year period. The most common presentation was dyspnea (34.6%) and the surgical procedure predominantly used was total thyroidectomy. The RSGs were removed by collar incision in 96% of the cases. The final histological diagnosis revealed malignancy in 26.9% of the thyroid specimens. There was no mortality and minor complications occurred in nine patients.

CONCLUSIONS:

The presence of an RSG is an indication for surgery owing to the lack of effective medical treatment, the higher incidence of symptoms related to compression, low surgical morbidity, and the risk of malignancy.

Keywords: Retrosternal goiter, surgery, thyroidectomy

Goiter is a term derived from the Latin tumidum gutter, meaning swollen throat, and is defined as a thyroid gland that is twice the normal size or over 40 g.[1] Retrosternal, substernal, intrathoracic or mediastinal are terms that have been used to describe a goiter that extends beyond the thoracic inlet. They have been observed in 1–20% of the patients undergoing thyroidectomy.[2,3] These rare entities may remain asymptomatic for a long time according to different reports.[46] However, they have the potential for sudden enlargement secondary to hemorrhage, cystic degeneration or malignant change, and asphyxiation, which can be life threatening.[7] Surgery plays an important role in the treatment of these patients, but whether all or selective patients with retrosternal goiter (RSG) should undergo the operation remains controversial.[8] As local data are lacking, we present our experience with the surgical management of RSG, and we have conducted this study with the aim of defining the characteristic findings of our patients with respect to the demographic variables, clinical presentation, the pathological state of the goiters, and essentially the role of surgery in its treatment.

Methods

Between June 2003 and June 2010, 537 patients underwent thyroid surgery at King Khalid University Hospital. Of them, 26 patients (4.8%) fit the diagnostic criteria of RSG and were enrolled in this study. The medical records of these patients were retrospectively analyzed. An RSG was diagnosed when the majority (>50%) of the gland was located below the thoracic inlet in the computerized tomogram (CT) scan. Large thyroid masses with their inferior borders at the thoracic inlet were not included. All patients had undergone investigations of thyroid namely; thyroid function tests, ultrasonography, chest X-ray, indirect laryngoscopy, fine needle aspiration (FNA), and CT scan of the neck and chest.

In selected patients (38%), thyroid scintigraphy was performed. Pulmonary function tests were performed in eight patients (36.7%) who presented with dyspnea. All patients underwent thyroid surgery and were evaluated with respect to their demographics, surgical procedures, and thyroid gland localization, during surgery, histopathological results, and postoperative complications.

Postoperative hypoparathyroidism was defined as symptomatic hypocalcemia that required calcium supplementation. It was considered permanent if the patient still required calcium supplement six months postoperatively.

Results

The ratio of thyroidectomies due to RSG to all thyroidectomies in this population was 4.8%. The median age was 54 years (range 32–77 years) and there were 20 female patients. The patients’ characteristics are summarized in Table 1. All patients were euthyroid except one patient who had a toxic goiter, which was controlled preoperatively. The most common presentation was dyspnea, occurring in 34.6% of the patients followed by neck swelling in 30.8% of the patients [Table 2]. There was no significant comorbidity and all the patients were offered surgery. The surgical procedure predominantly used was total thyroidectomy (42.3%) and the final histological diagnosis revealed malignancy in 26.9% of the specimens [Table 1]. There were five papillary and two follicular carcinomas. All malignancies were detected only after the final histology. No formal neck dissection was performed, but lymph nodes in zones 6 and 7 were removed along with the retrosternal part of the goiter.

Table 1
Patient characteristics
Table 2
Symptoms or signs in patients with retrosternal goiter

Median sternotomy was needed in only one patient and in 96% of the patients, cervical collar incision was adequate for the removal of these masses. There were no perioperative deaths and morbidities were minimal, as minor complications occurred in nine patients; most of them resolved completely [Table 3]. All patients received the thyroid stimulating hormone (TSH)-suppressive treatment with the thyroid hormone postoperatively. There was no recurrence during an average follow-up period of two years (range three months to seven years).

Table 3
Postoperative complications in nine patients operated on for retrosternal goiter

Discussion

At present, many different treatment modalities have been described for the management of goiters. As early as 2400 BC, the Chinese discovered that the ingestion of seaweed was potent in the treatment of goiter.[9] However, they did not realize that it was the iodine present in the seaweed that was responsible for the therapeutic effects.

Retrosternal goiter was first described by Haller in 1749.[10] The incidence of RSG is reported to range from 3 to 20% of the patients undergoing thyroid surgery.[2,3] This wide range in the incidence is mainly due to the variation in the definition of RSG.[11] Four definitions of RSG are identified: A thyroid in which any part of it extends below the thoracic inlet,[12] a gland reaching the aortic arch,[13] a thyroid reaching the level of T4 (on chest X-ray),[14] and greater than 50% (or the majority) of the gland residing below the thoracic inlet.[15] We have used the last definition in the present series. Several factors favor the passage of the goiter into the mediastinum: Downward traction caused by normal swallowing, respiration creating negative intrathoracic pressure, and the pull of gravity on the goiter.[16] Although the epidemiology of the RSG varies according to the definition, the incidence, sex ratio, and mean age in our series are in-keeping with other reports.[17,18]

The most common symptom in our series was dyspnea, occurring in 34.6% of the cases. The most common symptoms of RSG resulted from compression of the trachea or the esophagus or both.[19,20] This complication was caused by the progressive nature of the disease, combined with the narrow passage of the inlet.[21] A classical chest X-ray finding of the RSG included a mediastinal mass with tracheal deviation and compression, and visualization of the smooth or nodular outline of the tumor [Figure 1]. However, 30% of these patients may have a completely normal chest X-ray (to be consistent, chest X-ray or radiograph).[22] In our series, 20% of chest X-rays were normal. All patients had an ultrasound as part of the routine evaluation of goiters, which suspected the retrosternal extension in some patients; however, the ultrasound could not provide detailed information about the RSG.

Figure 1
Chest X.ray of a patient showing a large retrosternal goiter, with deviation of the trachea

A CT scan can showed the relationship of the goiter with the trachea, the esophagus, and great vessels, as well as how deeply into the chest the gland descends[23] [Figure 2]. In this series, a CT scan was performed routinely for all patients. Although the CT scan is the most useful tool in the detailed assessment of a relevant anatomy, it is not routinely performed in all centers.[24] Some of our patients, during the early phase of our study, underwent nuclear imaging (any specific indication for those undergoing nuclear imaging?), but neither nuclear imaging nor sonography is essential for the preoperative evaluation of known RSG.[25] An esophagogram can confirm esophageal compression, but it does not add much to its management.[26]

Figure 2
CT scan of the chest showing the relationship of the goiter with the trachea and the mediastinum

An FNA biopsy of an RSG may be helpful when a large cervical component exists, but this is not usually recommended, because it is technically difficult, may be dangerous to perform, and can miss the true pathology.[4,5] The majority of our patients presented with a multinodular goiter (MNG). An MNG adversely affects the preoperative diagnosis of thyroid cancer with FNA, as it is particularly impossible to evaluate all of the nodules. Thyroid cancer is frequently an incidental postoperative finding originating from one of the numerous nodules, although the FNA biopsy result is reported as benign. In our series only one patient presented with toxic goiter. The reported incidence of hyperthyroidism in patients with RSG varies widely from 0 to 50%.[6] None of our patients with RSG was treated medically. Trials of thyroid suppression with L-thyroxine therapy had little effect on disease progression.

The surgical treatment of goiter was contemplated as early as 900 AD by an Arabic surgeon named Abucasis. Denoting goiters as ‘elephants of the throat’, Abucasis has recorded that a goiter resembles the tumor from an arterial aneurysm,[27] and furthermore he has stated that it is dangerous to incise it. As Abucasis had done over 1,000 years before, Robert Liston, a prominent surgeon of his time, also warned surgeons against the performance of thyroidectomies.[28]

In the present series, with the exception of one patient (4%) among all the RSGs, sternotomy could be avoided. Although it is reported that the majority of cervicomediastinal type goiters can be removed through a conventional cervical approach,[13] the surgical approach required for RSG is the subject of significant debate.[29] Our patient who needed a sternotomy (originally described in a case report),[30] was on treatment for asthma for a long time and presented as an emergency with respiratory distress. The goiter was extending down to the level of the pulmonary trunk and during the operation there were engorged veins rendering blind manipulation almost impossible. Similar approaches for similar presentations have been described before.[31,32] More than 50% of our patients had more extensive surgeries (total and near total thyroidectomies). Performing extensive thyroid resection eliminated the need for reoperation, if a thyroid cancer was incidentally diagnosed postoperatively.[33]

In the present report, although postoperative morbidity was minimal, temporary hypoparathyroidism was the most common (15.4%). Some authors reported that temporary hypoparathyroidism seemed to occur more often after thyroidectomy for RSG, than after a standard thyroidectomy.[34] The incidence of malignancy in this series was 26.9% in the final histopathological diagnosis. This was much higher than in the reported incidences of malignancy in RSG, in different series,[5,11] as we have shown in a previous report.[35] However, the predominance of well-differentiated carcinoma in our patients goes in line with the previous reports.[36]

In conclusion, the poor response of RSG to medical treatment, the higher incidence of symptoms related to compression, difficulty in following clinically, the risk of malignancy, and development of acute airway obstruction, make the presence of RSG an indication for surgery. Cervical incision is nearly always adequate, with negligible operative mortality and minimal complications.

Acknowledgment

This study was funded by the College of Medicine Research Center, Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia.

Footnotes

Source of Support: College of Medicine Research Center, Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia

Conflict of Interest: None declared.

References

1. Newman E, Shaha AR. Substernal goiter. J Surg Oncol. 1995;60:207–12. [PubMed]
2. Torre G, Borgonovo G, Amato A. Surgical management of substernal goiter: Analysis of 237 patients. Am Surg. 1995;61:826–31. [PubMed]
3. Moran JC, Singer JA, Sardi A. Retrosternal goiter: A six-year Institutional Review. Am Surg. 1998;9:89–93. [PubMed]
4. Armour RH. Retrosternal goiter. Br J Surg. 2000;87:519. [PubMed]
5. Singh B, Lucente FE, Sahara AR. Substernal goiter: A clinical review. Am J Otolaryngol. 1994;15:409–16. [PubMed]
6. Madjar S, Weisberg D. Retrosternal goiter. Chest. 1995;60:207–12.
7. Cho HT, Cohen JP, Som ML. Management of substernal and intratoracic goiters. Otolaryngol Head Neck Surg. 1986;94:282–7. [PubMed]
8. Sanders LE, Rossi RL, Shahian DM, Williamson WA. Mediastinal goiters. The need for an aggressive approach. Arch Surg. 1992;127:609–13. [PubMed]
9. Langer P. Monograph Series 44. Geneva, Switzerland: World Health Organization; 1960. History of goiter, in endemic goiter. World Health Organization; pp. 9–25.
10. Haller A. Disputationes Anatomicae Selectae, Gottingen. Holland: Vandenhoeck; 1749. p. 96.
11. Wright D, Mathisen DJ. Mediastinal tumors: Diagnosis and treatment. World J Surg. 2001;25:204–9. [PubMed]
12. Cougard P, Matet P, Goudet P, Bambili R, Viard H, Vaillant G, et al. Les goiters plongeants: 218 cas operes. Ann Endocrinol (Paris) 1992;53:230–5. [PubMed]
13. Vadasz P, Kotsis L. Surgical aspects of 175 mediastinal goiters. Eur J Cardiothorac Surg. 1998;14:393–7. [PubMed]
14. Chow TL, Chan TT, Suen DT, Chu DQ, Lam SH. Surgical management of substernal goiter: Local experience. Hong Kong Med J. 2005;11:360–5. [PubMed]
15. deSouza FM, Smith PE. Retrosternal goiter. J Otolaryngol. 1983;12:393–6. [PubMed]
16. Sianesi M, Del Rio P, Arcuri MF, Soliani P, Rusca M. Cervicomediastinal goiter. Chir Ital. 2002;54:15–8. [PubMed]
17. Maruotti RA, Zannini P, Viani MP. Surgical treatment of substernal goiters. Int Surg. 1991;76:12–7. [PubMed]
18. Katlic MR, Grillo HC, Wang C. Substernal goiter (analysis of 80 patients from Massachusetts General Hospital) Am J Surg. 1985;149:283–7. [PubMed]
19. Anci C, Dertsiz L, Altumbas H, Demircan A, Emek K. Operative management of substernal goiter: Analysis of 52 patients. Int Surg. 2001;86:220–4. [PubMed]
20. Poglio F, Paolasso I, Falcone Y, Grimaldi S, Cocito D. Upper airways obstruction due to Retrosteral goiter in a patient with mythenia gravis. Neurol Sci. 2010;31:407–8. [PubMed]
21. Madjar S, Weissberg D. Retrosternal goiter. Chest. 1995;108:78–82. [PubMed]
22. Makeieff M, Marier F, Khudjadze M, Garrel R, Crampette L, Guerrier B. Substernal goiter: Report of 212 cases. Ann Chir. 2000;125:18–25. [PubMed]
23. Sanders LE, Rossi RL, Shahian DM, Williamson WA. Mediastinal goiters: The need for an aggressive approach. Arch Surg. 1992;127:609–13. [PubMed]
24. Bashist B, Ellis K, Gold RP. Computed tomography of intrathoracic goiters. Am J Radiol. 1983;140:455–60. [PubMed]
25. Porzio S, Marocco M, Oddi A, Lombardi V, Porzio O, Calvelli C, et al. Endothoracic Goiter: Anatomoclinical and therapeutic consideration. Chir Ital. 2001;53:453–60. [PubMed]
26. Alfonso A, Christoudias G, Amaruddin Q. Tracheal or esophageal compression due to benign thyroid disease. Am J Surg. 1981;142:350–4. [PubMed]
27. Spink MS, Lewis GL, editors. Albucasis on surgery and instruments. Los Angeles, CA: University California; 1973. p. 340.
28. Liston R. In: Lectures of the operations and on diseases and accidents requiring operations with numerous. Mutter TD, Robert L, editors. Philadelphia: PA Book in English; 1846. 1794-1847.
29. Huins CT, Georgalas C, Mehrzad H, Tolley NS. A new classification system for retrosternal goiter based a systematic review of its complications and management. Int J Surg. 2008;6:71–6. [PubMed]
30. Khairy G, AlSaif A. Large retrosternal goiter. A diagnostic and treatment dilemma. Oman Med J. 2010;25:154–7.
31. Flati G, Degiacomo T, Porowska B, Flati D, Gaj F, Talarico C, et al. Surgical management of substernal goiters.When is sternotomy inevitable? Clin Ter. 2005;156:191–5. [PubMed]
32. Irfan M, Jihan WS, Shahid H. Massive goiter with retrosternal extension encasing trachea and Oesophagus. Med J Malaysia. 2010;65:85–6. [PubMed]
33. Erbil Y, Bozbora A, Barbaros U, Ozarmagan S, Azezli A, Molvalilar S. Surgical management of substernal goiters: Clinical experience of 170 cases. Surg Today. 2004;34:732–6. [PubMed]
34. Ozdemir A, Hasbahceci M, Hamaloglu E, Ozenic A. Surgical treatment of substernal goiter. Int Surg. 2000;85:194–7. [PubMed]
35. Khiary GA. Solitary thyroid nodule: The risk of cancer and the extent of surgical therapy. East Afr Med J. 2004;81:459–62. [PubMed]
36. Shaha AR, Burnett C, Alfonso A, Jaffe BM. Goiters and air way problems. Am J Surg. 1989;158:378–80. [PubMed]

Articles from Annals of Thoracic Medicine are provided here courtesy of Medknow Publications